54 related articles for article (PubMed ID: 18547944)
1. Hospital Procalcitonin Testing and Antibiotic Treatment of Patients Admitted for Chronic Obstructive Pulmonary Disease Exacerbation.
Lindenauer PK; Shieh MS; Stefan MS; Fisher KA; Haessler SD; Pekow PS; Rothberg MB; Krishnan JA; Walkey AJ
Ann Am Thorac Soc; 2017 Dec; 14(12):1779-1785. PubMed ID: 28795838
[TBL] [Abstract][Full Text] [Related]
2. A Systematic Review of the Pulmonary Microbiome in Patients with Acute Exacerbation COPD Requiring ICU Admission.
van der Bie S; Haaksma ME; Vermin B; van Assema H; van Gorp ECM; Langerak T; Endeman H; Snijders D; van den Akker JPC; van Houten MA; van Lelyveld SFL; Goeijenbier M
J Clin Med; 2024 Jan; 13(2):. PubMed ID: 38256606
[No Abstract] [Full Text] [Related]
3. Different oxygenation targets for stable COPD and acute exacerbations in the ICU. Author's reply.
Qian F; van den Boom W; See KC
Intensive Care Med; 2023 Nov; 49(11):1430-1432. PubMed ID: 37750903
[No Abstract] [Full Text] [Related]
4. Serum Procalcitonin as a Biomarker for the Prediction of Bacterial Exacerbation and Mortality in Severe COPD Exacerbations Requiring Mechanical Ventilation.
Ergan B; Şahin AA; Topeli A
Respiration; 2016; 91(4):316-24. PubMed ID: 27081845
[TBL] [Abstract][Full Text] [Related]
5. Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD.
Tanrıverdi H; Örnek T; Erboy F; Altınsoy B; Uygur F; Atalay F; Tor MM
Wien Klin Wochenschr; 2015 Oct; 127(19-20):756-63. PubMed ID: 25586444
[TBL] [Abstract][Full Text] [Related]
6. Value of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease.
Lacoma A; Prat C; Andreo F; Lores L; Ruiz-Manzano J; Ausina V; Domínguez J
Int J Chron Obstruct Pulmon Dis; 2011; 6():157-69. PubMed ID: 21468168
[TBL] [Abstract][Full Text] [Related]
7. Procalcitonin and C-reactive protein in hospitalized adult patients with community-acquired pneumonia or exacerbation of asthma or COPD.
Bafadhel M; Clark TW; Reid C; Medina MJ; Batham S; Barer MR; Nicholson KG; Brightling CE
Chest; 2011 Jun; 139(6):1410-1418. PubMed ID: 21030489
[TBL] [Abstract][Full Text] [Related]
8. Optimal cut-off value of serum procalcitonin in predicting bacterial infection induced acute exacerbation in chronic obstructive pulmonary disease: A prospective observational study.
Ye YP; Zhao H; Kang T; Zhao LH; Li N; Chen J; Peng XX
Chron Respir Dis; 2022; 19():14799731221108516. PubMed ID: 35830291
[TBL] [Abstract][Full Text] [Related]
9. Biomarkers to guide the use of antibiotics for acute exacerbations of COPD (AECOPD): a systematic review and meta-analysis.
Hoult G; Gillespie D; Wilkinson TMA; Thomas M; Francis NA
BMC Pulm Med; 2022 May; 22(1):194. PubMed ID: 35549921
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory Biomarkers Are Inaccurate Indicators of Bacterial Infection on Admission in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease-A Systematic Review and Diagnostic Accuracy Network Meta-Analysis.
Pázmány P; Soós A; Hegyi P; Dohos D; Kiss S; Szakács Z; Párniczky A; Garami A; Péterfi Z; Molnár Z
Front Med (Lausanne); 2021; 8():639794. PubMed ID: 34869399
[No Abstract] [Full Text] [Related]
11. Biomarkers in Chronic Obstructive Pulmonary Disease: Emerging Roles of Eosinophils and Procalcitonin.
Sivapalan P; Jensen JU
J Innate Immun; 2022; 14(2):89-97. PubMed ID: 34428766
[TBL] [Abstract][Full Text] [Related]
12. Bacterial infections in acute exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis.
Moghoofei M; Azimzadeh Jamalkandi S; Moein M; Salimian J; Ahmadi A
Infection; 2020 Feb; 48(1):19-35. PubMed ID: 31482316
[TBL] [Abstract][Full Text] [Related]
13. Host-pathogen interaction during mechanical ventilation: systemic or compartmentalized response?
Keane S; Martin-Loeches I
Crit Care; 2019 Jun; 23(Suppl 1):134. PubMed ID: 31200727
[TBL] [Abstract][Full Text] [Related]
14. HL301 in the treatment of acute bronchitis: a phase 2b, randomized, double-blind, placebocontrolled, multicenter study.
Yoon SW; Park MJ; Rhee CK; Park JH; Lee SY; Kim DJ; Kim DG; Kim JY
Korean J Intern Med; 2020 Jan; 35(1):133-141. PubMed ID: 30962409
[TBL] [Abstract][Full Text] [Related]
15. The Use of Serum Procalcitonin as a Diagnostic and Prognostic Biomarker in Chronic Obstructive Pulmonary Disease Exacerbations: A Literature Review Update.
Pantzaris ND; Spilioti DX; Psaromyalou A; Koniari I; Velissaris D
J Clin Med Res; 2018 Jul; 10(7):545-551. PubMed ID: 29904438
[TBL] [Abstract][Full Text] [Related]
16. The recent advances of phenotypes in acute exacerbations of COPD.
Zhou A; Zhou Z; Zhao Y; Chen P
Int J Chron Obstruct Pulmon Dis; 2017; 12():1009-1018. PubMed ID: 28392685
[TBL] [Abstract][Full Text] [Related]
17. Potentially preventable hospitalizations for acute and chronic conditions in Alaska, 2010-2012.
Gounder PP; Seeman SM; Holman RC; Rarig A; McEwen MK; Steiner CA; Bartholomew ML; Hennessy TW
Prev Med Rep; 2016 Dec; 4():614-621. PubMed ID: 27920972
[TBL] [Abstract][Full Text] [Related]
18. The role of toll-like receptors in acute and chronic lung inflammation.
Lafferty EI; Qureshi ST; Schnare M
J Inflamm (Lond); 2010 Nov; 7():57. PubMed ID: 21108806
[TBL] [Abstract][Full Text] [Related]
19. Factors predicting bacterial involvement in severe acute exacerbations of chronic obstructive pulmonary disease.
Nseir S; Cavestri B; Di Pompeo C; Diarra M; Brisson H; Lemyze M; Roussel-Delvallez M; Durocher A
Respiration; 2008; 76(3):253-60. PubMed ID: 18547944
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
